These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25563588)

  • 1. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?
    Ayez N; Lalmahomed ZS; van der Pool AE; Vergouwe Y; van Montfort K; de Jonge J; Eggermont AM; Ijzermans JN; Verhoef C
    Ann Surg Oncol; 2011 Oct; 18(10):2757-63. PubMed ID: 21638093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
    Wimmer K; Schwarz C; Szabo C; Bodingbauer M; Tamandl D; Mittlböck M; Kaczirek K
    Ann Surg Oncol; 2017 Jan; 24(1):236-243. PubMed ID: 27730370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.
    Barkhatov L; Fretland ÅA; Kazaryan AM; Røsok BI; Brudvik KW; Waage A; Bjørnbeth BA; Sahakyan MA; Edwin B
    J Surg Oncol; 2016 Nov; 114(6):757-763. PubMed ID: 27471127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical risk score predicts the effectiveness of adjuvant chemotherapy for colorectal liver metastasis.
    Nakai T; Ishikawa H; Tokoro T; Okuno K
    World J Surg; 2015 Jun; 39(6):1527-36. PubMed ID: 25677009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
    Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
    Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
    van Amerongen MJ; van der Stok EP; Fütterer JJ; Jenniskens SF; Moelker A; Grünhagen DJ; Verhoef C; de Wilt JH
    Eur J Surg Oncol; 2016 Apr; 42(4):523-30. PubMed ID: 26856957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
    Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
    J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
    Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy.
    Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
    Ann Surg Oncol; 2014 Jan; 21(1):139-46. PubMed ID: 24121880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis.
    Strowitzki MJ; Schmidt T; Keppler U; Ritter AS; Mahmoud S; Klose J; Mihaljevic AL; Schneider M; Büchler MW; Ulrich AB
    J Surg Oncol; 2017 Aug; 116(2):149-158. PubMed ID: 28409832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
    Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M
    J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.